1. Home
  2. SBLK vs TLX Comparison

SBLK vs TLX Comparison

Compare SBLK & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Star Bulk Carriers Corp.

SBLK

Star Bulk Carriers Corp.

HOLD

Current Price

$24.91

Market Cap

2.5B

ML Signal

HOLD

Logo Telix Pharmaceuticals Limited American Depositary Shares

TLX

Telix Pharmaceuticals Limited American Depositary Shares

HOLD

Current Price

$10.72

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBLK
TLX
Founded
2006
2015
Country
Greece
Australia
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.2B
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
SBLK
TLX
Price
$24.91
$10.72
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$22.00
$21.13
AVG Volume (30 Days)
968.4K
219.4K
Earning Date
05-13-2026
08-19-2026
Dividend Yield
2.33%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$11.56
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$47.06
$150.33
Revenue Growth
N/A
N/A
52 Week Low
$13.92
$6.28
52 Week High
$27.20
$19.93

Technical Indicators

Market Signals
Indicator
SBLK
TLX
Relative Strength Index (RSI) 59.68 68.84
Support Level $21.71 $10.60
Resistance Level $27.20 $11.28
Average True Range (ATR) 0.75 0.33
MACD 0.11 0.05
Stochastic Oscillator 82.13 69.88

Price Performance

Historical Comparison
SBLK
TLX

About SBLK Star Bulk Carriers Corp.

Star Bulk Carriers Corp provides seaborne transportation solutions in the dry bulk sector. The company owns and operates dry bulk carrier vessels, which are used to transport bulk, such as iron ore, coal, grains, bauxite, fertilizers, and steel products. It owns a fleet of vessels that consists of Newcastlemax, Capesize, Post Panamax, Kamsarmax, Panamax, Ultramax, and Supramax. The firm generates the majority of its revenue from Time charters and Voyage charters.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: